Results 101 to 110 of about 684 (141)

Polymorphic forms of bisoprolol fumarate

Journal of Thermal Analysis and Calorimetry, 2018
Adam Detrich
exaly   +2 more sources

Method of Validation for Residual Solvents in Bisoprolol Fumarate by GC Technique

Asian Journal of Pharmaceutical Research, 2021
Validation is important technique for detection, progress and estimation of drugs for pharmaceutical analysis. Aim of this article was to check the progress and validation of the method employed for the Residual Solvents in Bisoprolol Fumarate by Gas Chromatographic technique.
Sandip A Telavane, Seema Kothari, Manohar V. Lokhande   +2 more
openaire   +1 more source

Incompatibility of Bisoprolol Fumarate with Some Super-disintegrating Agents

British Journal of Pharmaceutical Research, 2015
Aims: Bisoprolol fumarate, a selective β1adrenoreceptor blocker, is usually formulated as immediate release tablet dosage form. While developing the immediate release tablet formula in laboratory, the assay and dissolution results were found below acceptance limit in some formulation. The formulations differed only in disintegrating agents. Therefore a
Abu Shakar, Md Hossain, Ruhul Kayesh, Asma Rahman, Md Sultan   +4 more
openaire   +1 more source

SIMULTANEOUS ESTIMATION OF IVABRADINE HCl AND BISOPROLOL FUMARATE BY UV-SPECTROSCOPIC METHOD

GLOBAL JOURNAL FOR RESEARCH ANALYSIS, 2022
A simple UV spectrophotometric analytical method has been developed for simultaneous estimation of Ivabradine HCl and Bisoprolol used in the treatment of angina pectoris. Modied simultaneous equation method was developed with double beam UV-Visible spectrophotometer using water as a solvent.
Pushpak Pandit, Vraj Sheth, Savan Viradiya, Mansi Patel, Dimal A. Shah, Usmangani K. Chhalotiya   +5 more
openaire   +1 more source

Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Bisoprolol Fumarate

Journal of Pharmaceutical Sciences, 2014
Literature data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of immediate-release (IR) solid oral dosage forms containing bisoprolol as the sole active pharmaceutical ingredient (API) are reviewed.
Charoo, NA, Shamsher, AAA, Lian, LY, Abrahamsson, B, Cristofoletti, R, Groot, DW, Kopp, S, Langguth, P, Polli, J, Shah, VP, Dressman, J   +10 more
openaire   +3 more sources

Bisoprolol Fumarate: An Exploration on its Properties and Analytical Methods

Palestinian Medical and Pharmaceutical Journal
Cardiovascular diseases stay ahead and are the zenith reason for global death, with a pro-jected number of 17.9 million deaths in 2016 (i.e. 31% of global deaths). One of the third important threat cause of cardiovascular mortality is hypertension (high blood pressure). The US Food and Drug Organization (FDA) supported the use of Bisoprolol fumarate as
Manoj Verma, Swati Pandey, Bina Gidwani, Ravindra Kumar Pandey, Shiv Shankar Shukla   +4 more
openaire   +1 more source

RP-HPLC method for simultaneous estimation of bisoprolol fumarate and hydrochlorothiazide in tablet formulation

Journal of Pharmaceutical and Biomedical Analysis, 2010
A simple, precise and stability-indicating HPLC method was developed and validated for the simultaneous determination of bisoprolol fumarate and hydrochlorothiazide in pharmaceutical dosage form. The method involves the use of easily available inexpensive laboratory reagents. The separation was achieved on an Inertsil ODS 3V (25cmx4.6mm) 5microm column
Sneha J, Joshi, Pradnya A, Karbhari, Suvarna I, Bhoir, K S, Bindu, Chhanda, Das   +4 more
openaire   +2 more sources

Degradation of Bisoprolol Fumarate in Tablets Formulated with Dicalcium Phosphate

Drug Development and Industrial Pharmacy, 1995
Degradation of Bisoprolol Fumarate in tablet dosage forms was accelerated when granular Dicalcium Phosphate Anhydrous USP was substituted for milled Dicalcium Phosphate Anhydrous USP.
openaire   +1 more source

Spectrophotometric method for estimation of bisoprolol fumarate in tablets.

Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi, 2014
Bisoprolol fumarate is prescribed for the treatment of hypertension and angina pectoris.The purpose of this study was to develop a simple, sensitive, accurate, and reproducible method for estimation of bisoprolol fumarate in tablets.The proposed method was based on a yellow colored complex formed with tropaeolin 00, extractable in dichloromethane with ...
Alina Diana, Panainte, Nela, Bibire, Gladiola, Tântaru, M, Apostu, Mădălina, Vieriu, V, Dorneanu   +5 more
openaire   +1 more source

Development and Evaluation of Bilayer Tablets of Bimodal release of Bisoprolol Fumarate

Research Journal of Pharmaceutical Dosage Forms and Technology
Bisoprolol is a type of antihypertensive drug (β-blocker). It is a poorly water-soluble and highly permeable drug that belongs to class II biopharmaceutical classification. This investigation represents the formulation development of bisoprolol to immediate and sustained the drug release.
Vinay R. Kothawade, Yashpal M. More, Pallavi P. Ahire   +2 more
openaire   +1 more source